drugset / Trial / NCT03246971

Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain

NCT03246971 ↗

Phase 2 Completed 125 enrolled iX Biopharma Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the safety and effectiveness of Wafermine™ for post-bunionectomy or post-abdominoplasty pain over a 24 hours period. For subjects undergoing bunionectomy, 2 out of 3 subjects will receive Wafermine™ and 1 out of 3 subjects will receive placebo. For subjects undergoing abdominoplasty, 3 out of 4 subjects will receive Wafermine™ and 1 out of 4 subjects will receive placebo.

Timeline

Start
2017-08-24
Primary completion
2018-07-12
Completion
2018-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 25 mg Other
Subject Ketamine Small molecule 50 mg Other
Subject Ketamine Small molecule 75 mg Other

Indications